mRNA |
tanespimycin:bortezomib (250:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.077 |
0.04 |
mRNA |
CUDC-101 |
GDSC1000 |
pan-cancer |
AAC |
-0.07 |
0.04 |
mRNA |
ML083 |
CTRPv2 |
pan-cancer |
AAC |
0.078 |
0.04 |
mRNA |
CIL41 |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.04 |
mRNA |
Topotecan |
CCLE |
pan-cancer |
AAC |
-0.088 |
0.04 |
mRNA |
Axitinib |
FIMM |
pan-cancer |
AAC |
-0.34 |
0.04 |
mRNA |
BRD-K49290616 |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
0.04 |
mRNA |
erastin |
CTRPv2 |
pan-cancer |
AAC |
-0.069 |
0.04 |
mRNA |
LY-2183240 |
CTRPv2 |
pan-cancer |
AAC |
-0.062 |
0.05 |
mRNA |
selumetinib:UNC0638 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.05 |